Liz CareyMergers & Acquisitions$16.5B CDMO deal unhindered by role in broader pharma supply chainNovo Holdings greenlighted by European Commission to take control of U.S.-based CDMO.December 11, 2024GuidelineUSPSTF proposes new cervical cancer screening guidelinesWhile some signals abroad favor HPV DNA testing, USPSTF stays focused on cervical cytology alone or in combination.December 11, 2024MicrobiologyNationwide claims analysis questions value of multiplex molecular panels for UTIReimbursement for molecular syndromic panel testing for UTI may continue to face uncertainty.December 10, 2024FDA Warning LetterFDA sounds bacteria alarms over CGMP violations in MaineTom's troubles highlight the importance of being inspection-ready.November 21, 2024Clinical TrialLarge language models tapped for speeding up clinical trial enrollment in U.S.Meanwhile, the FDA envisions integrating more clinical trial activities into local healthcare facilities, roaming mobile research units, and through at-home lab testing kits.November 19, 2024SequencingAMP reviews pitfalls of NGS testing for SARS-CoV-2Document offers key pre-analytical, analytical, and post-analytical considerations to help improve NGS-based surveillance programs.November 15, 2024Diagnostic TechnologiesFDA fall IVD roundtable avoids LDT questionsIn addition, CAP LDT webinar offers beginning guide for phase one compliance.November 12, 2024Molecular DiagnosticsFulgent Genetics wins $99M precision medicine contract with VAThe new award maintains Fulgent's focus on germline testing and also funds pharmacogenetic (PGx) testing.October 31, 2024Pathology and AIDigital pathology rollouts race for proof-of-concept at national levelU.K. invests in clinical trial security while Australia's health minister issues powerful ultimatum.October 29, 2024ImmunoassaysLucy Letby murder case flags immunoassays as unreliable for medical evidenceAt least one pathologist has said it was wrong for scientists representing Liverpool Clinical Laboratories to insist insulin poisoning was the only explanation in a series of high-profile newborn deaths in the U.K., The Telegraph reported.October 28, 2024Page 1 of 6Next PageTop StoriesMergers & Acquisitions$16.5B CDMO deal unhindered by role in broader pharma supply chainNovo Holdings greenlighted by European Commission to take control of U.S.-based CDMO.Business InsightsTexas lab owner accused of $79M RPP fraud schemeFDA Warning LetterFDA sounds bacteria alarms over CGMP violations in MaineResearch and DevelopmentRevvity broadens work in newborn testing for NHS EnglandSponsor ContentBody composition in patients treated with Ozempic